When the Expert Becomes the Patient: Lindsey Wahlstrom on What Clinical Research Gets Wrong About Families
A decade in patient recruitment did not prepare her for what it felt like to be on the other...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Approval FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
A decade in patient recruitment did not prepare her for what it felt like to be on the other...
Coherus cut 30% of staff; Gyre laid off post-acquisition. Sites lose study contacts, amendments stall, and monitoring gaps widen....
Nature Biotechnology's new FDR taxonomy arrives as omics-driven trials flood FDA submissions, here's what every biomarker strategist must understand...
At the device session of the FDA and Duke-Margolis rare disease workshop: why BCI trials resist blinding at a...
VK2735 moves 75% of patients down BMI category in 13 weeks, with systolic blood pressure and triglycerides also improving...
Clinical research sites cite trial complexity as their top operational challenge, with 41% naming it their leading concern in...
Tovorafenib reaches 50.9-month median time to next treatment in pediatric low-grade glioma, with 54% of patients remaining off therapy...
CagriSema weight loss reached 21% average reduction at lower doses in Phase 3 REDEFINE 9 trial, with favorable tolerability...
Lilly presents obesity drug data at ObesityWeek 2026, highlighting EloraTZP weight loss results and retatrutide's effects on sleep apnea.
FDA lifts clinical hold on ARD-101 for PWS hyperphagia after resolving a drug-drug interaction concern. Aardvark plans a new...